Mangalam Drugs & Organics Limited

NSEI:MANGALAM 株式レポート

時価総額:₹2.0b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Mangalam Drugs & Organics 配当金

配当金 基準チェック /06

Mangalam Drugs & Organics現在配当金を支払っていません。

主要情報

0%

配当利回り

0%

配当性向

業界平均利回り0.7%
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金₹0.500
一株当たり利益-₹5.73
3年後の配当利回り予想n/a

最近の配当金アップデート

更新なし

Recent updates

Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues Are Not Doing Enough For Some Investors

Aug 13
Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues Are Not Doing Enough For Some Investors

A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

May 23
A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Little Excitement Around Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues As Shares Take 25% Pounding

Mar 28
Little Excitement Around Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues As Shares Take 25% Pounding

Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Shares Lagging The Industry But So Is The Business

Feb 07
Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Shares Lagging The Industry But So Is The Business

Estimating The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Oct 20
Estimating The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?

Mar 29
Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?

These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively

May 31
These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively

A Look At The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Apr 06
A Look At The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt

Jan 03
We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt

Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly

May 23
Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly

Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?

Jan 04
Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?

Do Its Financials Have Any Role To Play In Driving Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Stock Up Recently?

Nov 12
Do Its Financials Have Any Role To Play In Driving Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Stock Up Recently?

A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Sep 20
A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Does Mangalam Drugs & Organics's (NSE:MANGALAM) Statutory Profit Adequately Reflect Its Underlying Profit?

Aug 05
Does Mangalam Drugs & Organics's (NSE:MANGALAM) Statutory Profit Adequately Reflect Its Underlying Profit?

We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt

Jul 01
We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt

決済の安定と成長

配当データの取得

安定した配当: MANGALAMの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。

増加する配当: MANGALAMの配当金が増加しているかどうかを判断するにはデータが不十分です。


配当利回り対市場

Mangalam Drugs & Organics 配当利回り対市場
MANGALAM 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (MANGALAM)0%
市場下位25% (IN)0.2%
市場トップ25% (IN)1.1%
業界平均 (Pharmaceuticals)0.7%
3年後のアナリスト予想 (MANGALAM)n/a

注目すべき配当: MANGALAMは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。

高配当: MANGALAMは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。


株主への利益配当

収益カバレッジ: MANGALAM Indian市場において目立った配当金を支払っていません。


株主配当金

キャッシュフローカバレッジ: MANGALAMが配当金を報告していないため、配当金の持続可能性を計算できません。


高配当企業の発掘